PHARMACOGENOMICS

Literals

• dcterms:coverage
  • 2000-2020
• vcard:country-name
  • United Kingdom
• ou:categoriaSJR
  • Molecular Medicine (Q2)
  • Genetics (Q3)
  • Pharmacology (Q2)
• ou:codigoRevista
  • 1462-2416
  • 1744-8042
• bibo:eissn
  • 1744-8042
• dcterms:identifier
  • 2014-5806
• bibo:issn
  • 1462-2416
• dcterms:publisher
  • Future Medicine Ltd.
• vcard:region
  • Western Europe
• ou:sjrMejorCuartil
  • Q2
• dcterms:title
  • PHARMACOGENOMICS

Typed Literals

• ou:sjr
  • 0.965 (http://www.w3.org/2001/XMLSchema#Decimal)

Inverse Relations

• Has related: ou:publicadaEnRevista
  • CYP2D6 gene polymorphisms and predicted phenotypes in eight indigenous groups from northwestern Mexico
  • CYP2D6 genetic polymorphisms in Southern Mexican Mayan Lacandones and Mestizos from Chiapas
  • Interview: Perspective on the use of genomic biomarkers in the clinical setting
  • Relationship between the CYP2C9 IVS8-109A>T polymorphism and high losartan hydroxylation in healthy Ecuadorian volunteers